BEAM
Price
$17.41
Change
+$0.16 (+0.93%)
Updated
May 9 closing price
Capitalization
1.75B
92 days until earnings call
ZETA
Price
$13.35
Change
+$0.04 (+0.30%)
Updated
May 9 closing price
Capitalization
2.36B
79 days until earnings call
Ad is loading...

BEAM vs ZETA

Header iconBEAM vs ZETA Comparison
Open Charts BEAM vs ZETABanner chart's image
Beam Therapeutics
Price$17.41
Change+$0.16 (+0.93%)
Volume$2.38M
Capitalization1.75B
Zeta Global Holdings
Price$13.35
Change+$0.04 (+0.30%)
Volume$2.89M
Capitalization2.36B
BEAM vs ZETA Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZETA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. ZETA commentary
May 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and ZETA is a Buy.

Ad is loading...
COMPARISON
Comparison
May 12, 2025
Stock price -- (BEAM: $17.41 vs. ZETA: $13.35)
Brand notoriety: BEAM and ZETA are both not notable
BEAM represents the Biotechnology, while ZETA is part of the Packaged Software industry
Current volume relative to the 65-day Moving Average: BEAM: 90% vs. ZETA: 57%
Market capitalization -- BEAM: $1.75B vs. ZETA: $2.36B
BEAM [@Biotechnology] is valued at $1.75B. ZETA’s [@Packaged Software] market capitalization is $2.36B. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The market cap for tickers in the [@Packaged Software] industry ranges from $3.15T to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B. The average market capitalization across the [@Packaged Software] industry is $12.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileZETA’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • ZETA’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than ZETA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while ZETA’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • ZETA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than ZETA.

Price Growth

BEAM (@Biotechnology) experienced а -13.98% price change this week, while ZETA (@Packaged Software) price change was -2.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

The average weekly price growth across all stocks in the @Packaged Software industry was +3.19%. For the same industry, the average monthly price growth was +10.88%, and the average quarterly price growth was +28.99%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

ZETA is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Packaged Software (+3.19% weekly)

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZETA($2.36B) has a higher market cap than BEAM($1.75B). ZETA YTD gains are higher at: -25.792 vs. BEAM (-29.798). ZETA has higher annual earnings (EBITDA): -124.36M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. ZETA (132M). BEAM has less debt than ZETA: BEAM (158M) vs ZETA (184M). ZETA has higher revenues than BEAM: ZETA (729M) vs BEAM (63.6M).
BEAMZETABEAM / ZETA
Capitalization1.75B2.36B74%
EBITDA-399.03M-124.36M321%
Gain YTD-29.798-25.792116%
P/E RatioN/AN/A-
Revenue63.6M729M9%
Total Cash1.22B132M924%
Total Debt158M184M86%
TECHNICAL ANALYSIS
Technical Analysis
BEAMZETA
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 6 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
73%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZETA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIRCX9.440.07
+0.75%
Fidelity Advisor Intl Real Estate C
RGGHX37.570.06
+0.16%
American Funds Global Balanced R2E
FAYZX13.840.01
+0.07%
Fidelity Advisor Multi-Asset Income I
USPCX27.33N/A
N/A
Union Street Partners Value C
WFDAX24.36-0.13
-0.53%
Allspring SMID Cap Growth Fund - Cl A

ZETA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZETA has been loosely correlated with PSFE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ZETA jumps, then PSFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZETA
1D Price
Change %
ZETA100%
+0.30%
PSFE - ZETA
54%
Loosely correlated
+0.59%
COIN - ZETA
51%
Loosely correlated
-3.48%
CLSK - ZETA
50%
Loosely correlated
+5.99%
PLUS - ZETA
48%
Loosely correlated
-2.46%
EVCM - ZETA
48%
Loosely correlated
+6.28%
More